申请人:SmithKline Beecham plc
公开号:US05571833A1
公开(公告)日:1996-11-05
The present invention relates to known and novel tryptamine analogues, processes and intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy, in particular for the treatment and/or prophylaxis of disorders characterized by excessive vasodilatation, such as migraine and portal hypertension.
本发明涉及已知和新颖的色胺类似物,用于制备它们的过程和中间体,含有它们的药物组合物以及它们在治疗中的使用,特别是用于治疗和/或预防由过度血管扩张所特征的疾病,如偏头痛和门静脉高压症。